ZINPLAVA 25 mg/mL
bezlotoxumab · INJECTION, SOLUTION · Merck Sharp & Dohme LLC
Zinplava is an intravenous injection used to reduce the risk of recurrent Clostridioides difficile infection in patients who are at high risk for recurrence. It works by neutralizing a toxin produced by the bacteria that causes this serious intestinal infection.
Key Facts
- Brand Name
- ZINPLAVA
- Generic Name
- bezlotoxumab
- NDC Code (Product)
0006-3025- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 25 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761046
- Marketing Start
- 10/21/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is ZINPLAVA used for?
Zinplava is an intravenous injection used to reduce the risk of recurrent Clostridioides difficile infection in patients who are at high risk for recurrence. It works by neutralizing a toxin produced by the bacteria that causes this serious intestinal infection.
Is ZINPLAVA a controlled substance?
ZINPLAVA is not classified as a controlled substance by the DEA.
What is the generic name for ZINPLAVA?
The generic name for ZINPLAVA is bezlotoxumab. There are no other listed brand versions of bezlotoxumab.
What is the NDC code for ZINPLAVA 25 mg/mL?
The NDC (National Drug Code) for ZINPLAVA 25 mg/mL is 0006-3025, listed by Merck Sharp & Dohme LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)